Adial Pharmaceuticals, Inc. (ADIL) Operating cash flow 2017–2025
Adial Pharmaceuticals, Inc. (ADIL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.5MFY2025 · since FY2017: -$494,862 → -$6.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.5M | +6.2% |
| FY2024 | -$6.9M | -1.7% |
| FY2023 | -$6.8M | +39.1% |
| FY2022 | -$11.2M | +6.4% |
| FY2021 | -$11.9M | -56.5% |
| FY2020 | -$7.6M | -20.4% |
| FY2019 | -$6.3M | -153.7% |
| FY2018 | -$2.5M | -404.9% |
| FY2017 | -$494,862 | — |
Source: SEC XBRL filings · For reference only · Not investment advice